AlphAIAlphAI — Financial news for AI agents
tradingview.comNOV 42 min read$MDLN

Medline Q3 Sales Rise 10.4% to $7.9 Billion; Net Income Falls 1.2%

Medline reported Q3 2026 net sales of $7.856B, up 10.4% YoY, but net income fell 1.2% to $318M. Adjusted EBITDA rose 11.8% to $960M. The company raised its full-year organic sales growth outlook to 10.0%-10.5% and reaffirmed Adjusted EBITDA guidance of $3.3B-$3.4B. Medline also announced a $1B share repurchase program and prepaid $750M of its 2033 term loan.

Original reporting
tradingview.com
Published Nov 4, 2026, 12:43 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 12:53 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Medline Q3 Sales Rise 10.4% to $7.9 Billion; Net Income Falls 1.2% — source image
Source · tradingview.com
Decision brief

The 30-second read

$MDLNBullishMed
01

Why it matters

The earnings release provides fresh data on revenue growth and guidance, influencing short‑term price action.

02

Market read

Earnings and guidance update are the primary market‑moving elements for MDLN.

03

What to watch

Automation investments and new distribution centers may drive future cost efficiencies not reflected yet.

Relevance 8/10Novelty 8/10Timing: post‑market today

Background

Medline Inc. (MDLN) reported Q3 2026 results, raising its organic sales growth outlook and reaffirming EBITDA guidance.

Company-level read

Ticker impact

$MDLNBullishHigh confidence
Context

Q3 2026 earnings released with sales up 10.4% YoY and guidance raised, providing fresh material data.

Expected impact

modest upside pressure as market prices in higher sales guidance, tempered by lower net income.

Evidence & confidence

New earnings and guidance are primary disclosure; investors will re‑price based on mixed signals.

Market effects

Sector

Healthcare distribution sector may see modest uplift from higher sales growth trends.

Regional

U.S. market participants focused on earnings; limited broader regional effect.

Global

Low global impact beyond Medline and its supply chain.

Counterpoint

What could challenge this read

Profit decline could signal margin pressure; investors may short on earnings disappointment.

Key entities

  • company
    Medline Inc.

    Healthcare supplies distributor reporting Q3 earnings.

Read at source← All news

StoryMedline raises full‑year organic sales outlook, launches $1 billion share buyback

Also covered by

5 outlets

Related articles

NOV 4
Low

Medline Q3 2026 slides: sales rise 10%, shares jump 15% on guidance

Medline Industries reported Q3 2026 net sales of $7.9B, up 10.4%, and adjusted EBITDA of $960M, up 11.8%. Shares rose 15.58% on raised guidance and a $1B share repurchase program. Organic sales grew 10.5%, with segment growth varying. Higher costs and lower-margin distribution impacted margins. The company expects continued growth and improved market share.

investing.com2 min
NOV 4
$MDLNHighAI 8/10

Medline: Q3 Earnings Snapshot

Medline Inc. (MDLN) reported Q3 earnings of $195 million, or 22 cents per share, beating analyst estimates of 34 cents per share. Adjusted earnings were 44 cents per share. Revenue was $7.86 billion, exceeding forecasts of $7.69 billion, according to Zacks Investment Research.

finance.yahoo.com2 min
NOV 4
$MDLNHighAI 9/10

Medline Reports Third Quarter and Nine Months 2026 Results

Medline Inc. (MDLN) filed an SEC Form 8-K — Results of Operations and Financial Condition. November 4, 2026 Medline Reports Third Quarter and Nine Months 2026 Results • Third quarter net sales of $7.9 billion, an increase of 10.4% • Third quarter net income of $318 million, a decrease of 1.2% • Third quarter Adjusted EBITDA 1 of $1.0 billion, an increase of 11.8% • Nin

SEC EDGAR 8-K2 min